Stel een vraag
Met het formulier hier onder kunt u contact op nemen met boekwinkel hasselman.
redactie - Background Paper Change Pain (For internal use only)
De vraag gaat over de volgende titel:
| Afbeelding: |
|
|---|---|
| Schrijver: | redactie |
| Titel: | Background Paper Change Pain (For internal use only) |
| ISBN: | |
| Uitgever: | GRUNENTHAL Achen |
| Bijzonderheid: | grote paperback 110pp. in goede staat, opstap voor nieuw pijnbestrijdingsmiddel (schaars) |
| Prijs: |
€ 23,70
€ 3,65
|
| Meer info | Dear colleague, we welcome you to an important part of the Integrated Prelaunch Campaign (IPLC) for our new productPalexia - the Cange Pain Background Paper Grünenthal From Wikipedia, the free encyclopedia Jump to navigationJump to search Unbalanced scales.svg A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (May 2020) (Learn how and when to remove this template message) Grünenthal GmbH Official logo of Grünenthal Aachen Grünenthal.jpg Headquarters of Grünenthal Formerly Chemie Grünenthal Type private company (GmbH) Industry pharmaceutical Founded 1946; 74 years ago in Stolberg, North Rhine-Westphalia, Germany Founder Hermann Wirtz, Sr. [de] Headquarters Aachen, North Rhine-Westphalia, Germany Number of locations 29 (commercial presence) 5 (manufacturing sites) Areas served +100 countries worldwide Key people Gabriel Baertschi (CEO) Fabian Raschke (CFO) Mark Fladrich (CCO) Jan Adams (CSO) Products Tapentadol Thalidomide Tramadol etc. Revenue Increase €1.4 billion (2019) Owner Wirtz family Number of employees Decrease 4,700 (2019) Website www.grunenthal.com Footnotes / references Corporate Profile Grünenthal is a pharmaceutical company headquartered in Aachen in Germany. The company was founded in 1946 as Chemie Grünenthal and has been continuously family-owned. The company was the first to introduce penicillin into the German market in the postwar period, after the Allied Control Council lifted its ban. Grünenthal became infamous in the 1950s and 1960s for the development and sale of the teratogenic drug thalidomide, marketed as the sleeping pill Contergan and promoted as a morning sickness preventative. Thalidomide caused severe birth defects, miscarriages, and other severe health problems. Though these side effects were proven conclusively in 1959,[1] and 1962,[2] Grünenthal continued marketing the drug well into the 1970s and 1980s.[3] The company generates more than 50 percent of its income with pain medications such as the drug Tramadol. The company has two offices in Germany as well as subsidiaries in Europe, Latin America, the US, and China. In November 2016, the company acquired Thar Pharmaceuticals [4] and in 2018 Averitas Pharma.[5] |
| Boek bekijken | |
Levering binnen de EU is mogelijk bij bestellingen vanaf 15 euro plus bijkomende internationale verzendkosten.
Afhalen is niet mogelijk.
De verkoper zal binnen 7 werkdagen contact met u opnemen om de koop verder af te handelen.